Last reviewed · How we verify
NCT04341272
Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis
NA trial testing Intermittent Pneumatic Compression Device (FDA approved) in Venous Thromboses in 106 participants. Completed in 5 April 2017.
5 April 2017
Quick facts
| Lead sponsor | Baltimore VA Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 106 |
| Start date | 1 April 2014 |
| Primary completion | 5 April 2017 |
| Estimated completion | 5 April 2017 |
Drugs / interventions tested
- Intermittent Pneumatic Compression Device (FDA approved)
Conditions studied
- Venous Thromboses — all drugs for Venous Thromboses →
Sponsor
Baltimore VA Medical Center
Who can join
18 and older, male only, with Venous Thromboses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Venous thromboembolism (VTE) is an important cause of morbidity and mortality following surgery.A combination of chemical and mechanical prophylaxis using lower extremity compression devices (CD) is recommended in patients who are considered at 'moderate risk' (Caprini score 2 - 4) or 'high risk' (Caprini score \> 4) of developing VTE. The aim of this study was to determine whether upper extremity (UE) CD are as effective as lower extremity (LE) CD in preventing VTE following surgery. A total of 106 patients were recruited.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04341272
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Thromboses
Currently open trials in the same condition.
- NCT06581965 — inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Tota · Phase 4 · recruiting
- NCT06087952 — Leiden Thrombosis Recurrence Risk Prevention · NA · active not recruiting
Other Baltimore VA Medical Center trials
Trials by the same sponsor.
- NCT03984994 — Muscle Capillarization and Sarcopenia · NA · completed
- NCT03556709 — Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project · NA · not yet recruiting
- NCT03530592 — Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project · NA · not yet recruiting
- NCT02992275 — NMES to Improve Hip Abductor Strength and Balance · NA · completed
- NCT00891514 — Trial of Aerobic Exercise Training in Stroke Survivors · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04341272 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baltimore VA Medical Center
- Last refreshed: 10 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04341272.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing